SRPT
Sarepta Therapeutics, Inc.Company with tickers: SRPT
CIK
873303
CUSIP
803607100
Shares Outstanding
105,576,222
13F Activity (30d)
273 filings
271 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $730,803,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Revenue (ASC 606) | $330,515,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | $358,433,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Net Income | $330,959,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $3.15 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $2.88 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |